GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » Accumulated other comprehensive income (loss)

Mega Lifesciences PCL (BKK:MEGA-R) Accumulated other comprehensive income (loss) : ฿88 Mil (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Mega Lifesciences PCL's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was ฿88 Mil.

Mega Lifesciences PCL's quarterly Accumulated other comprehensive income (loss) stayed the same from Sep. 2024 (฿88 Mil) to Dec. 2024 (฿88 Mil) and stayed the same from Dec. 2024 (฿88 Mil) to Mar. 2025 (฿88 Mil).

Mega Lifesciences PCL's annual Accumulated other comprehensive income (loss) stayed the same from Dec. 2022 (฿88 Mil) to Dec. 2023 (฿88 Mil) and stayed the same from Dec. 2023 (฿88 Mil) to Dec. 2024 (฿88 Mil).


Mega Lifesciences PCL Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Mega Lifesciences PCL's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Accumulated other comprehensive income (loss) Chart

Mega Lifesciences PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.05 74.09 88.21 88.21 88.21

Mega Lifesciences PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.21 88.21 88.21 88.21 88.21

Mega Lifesciences PCL Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Mega Lifesciences PCL Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Lifesciences PCL Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
Address
Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines